Cargando…
DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19
The Coronavirus Disease 2019 (COVID-19) pandemic is still wreaking havoc worldwide. Therefore, the urgent need for efficient treatments pushes researchers and clinicians into screening effective drugs. Drug repurposing may be a promising and time-saving strategy to identify potential drugs against t...
Autores principales: | Su, Yinchun, Wu, Jiashuo, Li, Xiangmei, Li, Ji, Zhao, Xilong, Pan, Bingyue, Huang, Junling, Kong, Qingfei, Han, Junwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121077/ https://www.ncbi.nlm.nih.gov/pubmed/37105108 http://dx.doi.org/10.1016/j.compbiomed.2023.106969 |
Ejemplares similares
-
PathwayTMB: A pathway-based tumor mutational burden analysis method for predicting the clinical outcome of cancer immunotherapy
por: Li, Xiangmei, et al.
Publicado: (2023) -
Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer
por: Wang, Qian, et al.
Publicado: (2022) -
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
por: Garana, Belinda B., et al.
Publicado: (2023) -
Enrichment analysis of phenotypic data for drug repurposing in rare diseases
por: Ambesi-Impiombato, Alberto, et al.
Publicado: (2023) -
Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)